Evidence map›Paper›PMID 30297159›Full record

ArticleJournal of autoimmunity2019

ARID3a gene profiles are strongly associated with human interferon alpha production.

Michelle L Ratliff, Joshua Garton, Lori Garman, M David Barron, Constantin Georgescu, Kathryn A White, Eliza Chakravarty, Jonathan D Wren, Courtney G Montgomery, Judith A James and 1 more

Abstract read
In one paragraph

Article in Journal of autoimmunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Autoimmunity in 2018.Clinical reviews in allergy & immunology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Michelle L RatliffDepartment of Medicine, Oklahoma City, OK, USA.
Joshua GartonDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, USA.
Lori GarmanArthritis and Clinical Immunology Program, Oklahoma City, OK, USA; Division of Genomics and Data Sciences, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
M David BarronDepartment of Microbiology and Immunology, Oklahoma City, OK, USA.
Constantin GeorgescuArthritis and Clinical Immunology Program, Oklahoma City, OK, USA.
Kathryn A WhiteArthritis and Clinical Immunology Program, Oklahoma City, OK, USA.
Eliza ChakravartyArthritis and Clinical Immunology Program, Oklahoma City, OK, USA.
Jonathan D WrenArthritis and Clinical Immunology Program, Oklahoma City, OK, USA; Department of Biochemistry, Oklahoma City, OK, USA.
Courtney G MontgomeryArthritis and Clinical Immunology Program, Oklahoma City, OK, USA; Division of Genomics and Data Sciences, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Judith A JamesDepartment of Medicine, Oklahoma City, OK, USA; Arthritis and Clinical Immunology Program, Oklahoma City, OK, USA; Department of Pathology, and Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Carol F WebbDepartment of Medicine, Oklahoma City, OK, USA; Department of Microbiology and Immunology, Oklahoma City, OK, USA; Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: carol-webb@ouhsc.edu.
Oklahoma City University · USOklahoma Medical Research Foundation · USUniversity of Oklahoma · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI TIMOTHY M VANWAGONER · 2013 to 2026
$68.2M
Understanding connective tissue development and disease with PDGFR-driven..... P20GM103636 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2013 to 2023
$26.9M
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)P30AR073750 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JUDITH A JAMES · 2018 to 2026
$8.5M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
Quantitative Analysis Core P30GM110766 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2014 to 2018
$6.1M
Molecular Basis of Immunity - Kirschtein-NRSAT32AI007633 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CUNNINGHAM, MADELEINE W. · 2001 to 2022
$4.0M
Role of the transcription factor ARID3a in innate immune responsesR01AI118836 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI WEBB, CAROL F · 2017 to 2020
$1.5M
Role of ARID3a in aging human hematopoietic progenitor cellsR00AG055717 · NIA · EAST CAROLINA UNIVERSITY · PI RATLIFF, MICHELLE LEIGH · 2020 to 2022
$734k
Role of the Transcription Factor ARID3a in Innate Immune ResponsesR56AI118836 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI WEBB, CAROL F · 2015 to 2015
$370k
Role of ARID3a in aging human hematopoietic progenitor cellsK99AG055717 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RATLIFF, MICHELLE LEIGH · 2017 to 2018
$189k
NIAID NIH HHS R01 AI118836NIAID NIH HHS R56 AI118836NIAID NIH HHS T32 AI007633NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P30 AR073750NIA NIH HHS K99 AG055717NIA NIH HHS R00 AG055717NIGMS NIH HHS P20 GM103636NIGMS NIH HHS P30 GM110766NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Type I interferons (IFN) causes inflammatory responses to pathogens, and can be elevated in autoimmune diseases such as systemic lupus erythematosus (SLE). We previously reported unexpected associations of increased numbers of B lymphocytes expressing the DNA-binding protein ARID3a with both IFN alpha (IFNα) expression and increased disease activity in SLE. Here, we determined that IFNα producing low density neutrophils (LDNs) and plasmacytoid dendritic cells (pDCs) from SLE patients exhibit strong associations between ARID3a protein expression and IFNα production. Moreover, SLE disease activity indices correlate most strongly with percentages of ARID3a

Indexed as

AdultAgedB-LymphocytesDendritic CellsDisease ProgressionDNA-Binding ProteinsFemaleGene Expression RegulationGenetic Association StudiesHumansImmunity, InnateInterferon-alphaLupus Erythematosus, SystemicMaleMiddle AgedNeutrophilsARID3A protein, humanDNA-Binding ProteinsInterferon-alphaTranscription FactorsARID3aInterferon alphaLow density neutrophilsLupusPlasmacytoid dendritic cells

Identifiers

PMID30297159
PMCPMC6497177
OpenAlexW2895034623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.